Clinical Trial

Effects of Transcranial Photobiomodulation in ADHD

Recruiting
View on ClinicalTrials.gov →
Summary
The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.
Protocol Amendment History 1 change
notable Sponsor changed: University of Texas at Austin -> Francisco Gonzalez-Lima, PhD 2026-06-23
Trial Details
NCT Number NCT07203092
Lead Sponsor Francisco Gonzalez-Lima, PhD
Conditions Attention Deficit Hyperactivity Disorder
Enrollment 140 participants
Start Date 2025-09-01
Primary Completion 2027-11 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-22